Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS codon 12 mutations in Australian non-small cell lung cancer.

Australian and New Zealand journal of medicine - 1 Apr 1998

Fong K M, Zimmerman P V, Smith P J

Abstract excerpt

BACKGROUND: In certain non-small cell lung cancer (NSCLC) populations, codon 12 mutations of the KRAS oncogene comprising mostly G-T transversions have diagnostic and prognostic value. However, it is not known if these findings are applicable to all populations of lung cancer patients. AIMS: To examine for KRAS codon 12 mutations in Australian NSCLC patients. METHODS: Tumour samples and corresponding normal lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Staging

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9612526
DOI: 10.1111/j.1445-5994.1998.tb02967.x

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS codon 12 mutations in Australian non-small cell lung cancer.PMID 9612526Read ↗

KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.Semantic proximity Read ↗

Prognostic value of specific KRAS mutations in lung adenocarcinomas.Semantic proximity Read ↗

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.Semantic proximity Read ↗

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre StudySemantic proximity Read ↗

Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?Semantic proximity Read ↗

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer.Semantic proximity Read ↗

Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.Semantic proximity Read ↗

Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.Semantic proximity Read ↗

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma.Semantic proximity Read ↗

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the LungSemantic proximity Read ↗

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.